ZA200108289B - Use of osanetant in the production of medicaments used to treat mood disorders. - Google Patents

Use of osanetant in the production of medicaments used to treat mood disorders.

Info

Publication number
ZA200108289B
ZA200108289B ZA200108289A ZA200108289A ZA200108289B ZA 200108289 B ZA200108289 B ZA 200108289B ZA 200108289 A ZA200108289 A ZA 200108289A ZA 200108289 A ZA200108289 A ZA 200108289A ZA 200108289 B ZA200108289 B ZA 200108289B
Authority
ZA
South Africa
Prior art keywords
osanetant
production
mood disorders
medicaments used
treat mood
Prior art date
Application number
ZA200108289A
Other languages
English (en)
Inventor
Xavier Emonds-Alt
Philippe Soubrie
Regis Steinberg
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of ZA200108289B publication Critical patent/ZA200108289B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
ZA200108289A 1999-04-13 2001-10-09 Use of osanetant in the production of medicaments used to treat mood disorders. ZA200108289B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904699A FR2792199B3 (fr) 1999-04-13 1999-04-13 Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur

Publications (1)

Publication Number Publication Date
ZA200108289B true ZA200108289B (en) 2002-12-24

Family

ID=9544412

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108289A ZA200108289B (en) 1999-04-13 2001-10-09 Use of osanetant in the production of medicaments used to treat mood disorders.

Country Status (24)

Country Link
US (1) US6420388B1 (et)
EP (1) EP1175215A2 (et)
JP (1) JP2002541190A (et)
KR (1) KR20010105418A (et)
CN (1) CN1354662A (et)
AR (1) AR023452A1 (et)
AU (1) AU3971600A (et)
BR (1) BR0009704A (et)
CA (1) CA2369638A1 (et)
CZ (1) CZ20013645A3 (et)
EE (1) EE200100527A (et)
FR (1) FR2792199B3 (et)
HR (1) HRP20010741A2 (et)
HU (1) HUP0200655A3 (et)
ID (1) ID30458A (et)
IS (1) IS6098A (et)
MX (1) MXPA01010340A (et)
NO (1) NO20014953L (et)
PE (1) PE20010032A1 (et)
PL (1) PL351554A1 (et)
SK (1) SK14552001A3 (et)
TR (1) TR200102930T2 (et)
WO (1) WO2000061125A2 (et)
ZA (1) ZA200108289B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE367811T1 (de) * 2000-06-12 2007-08-15 Univ Rochester Methode zur behandlung von hitzewallungen, durch verwendung eines tachikinin-rezeptor antagonisten
TWI329649B (en) * 2003-12-22 2010-09-01 Glaxo Group Ltd Immunoglobulins
US20070244152A1 (en) * 2004-03-25 2007-10-18 Lowy Martin T Use of an Nk3 Antagonist for the Treatment of Bipolar Disorders
WO2006098488A1 (ja) 2005-03-15 2006-09-21 Sumitomo Chemical Company, Limited 気分障害による疾患症状を改善させる方法
JP2006320201A (ja) * 2005-05-17 2006-11-30 Sumitomo Chemical Co Ltd 気分障害又は関連障害による疾患症状を改善させる方法
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
WO2015200594A2 (en) * 2014-06-25 2015-12-30 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
AU3971600A (en) 2000-11-14
CN1354662A (zh) 2002-06-19
EE200100527A (et) 2002-12-16
FR2792199B3 (fr) 2001-05-18
WO2000061125A2 (fr) 2000-10-19
KR20010105418A (ko) 2001-11-28
CA2369638A1 (en) 2000-10-19
HUP0200655A3 (en) 2002-11-28
JP2002541190A (ja) 2002-12-03
HUP0200655A2 (hu) 2002-07-29
NO20014953L (no) 2001-12-11
CZ20013645A3 (cs) 2002-01-16
TR200102930T2 (tr) 2002-04-22
EP1175215A2 (fr) 2002-01-30
MXPA01010340A (es) 2002-05-06
PL351554A1 (en) 2003-05-05
BR0009704A (pt) 2002-01-08
FR2792199A1 (fr) 2000-10-20
AR023452A1 (es) 2002-09-04
IS6098A (is) 2001-09-28
ID30458A (id) 2001-12-06
NO20014953D0 (no) 2001-10-11
HRP20010741A2 (en) 2002-10-31
US6420388B1 (en) 2002-07-16
WO2000061125A3 (fr) 2001-04-19
SK14552001A3 (sk) 2002-02-05
PE20010032A1 (es) 2001-04-11

Similar Documents

Publication Publication Date Title
IL163102A (en) Dihydrobenzodiazepin-2-one derivatives, process for their preparation and use thereof in the preparation of medicaments for the treatment of neurological disorders
AU9112201A (en) Pulmonary delivery in treating disorders of the central nervous system
HK1070361A1 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine
GB2349570B (en) Compositions for treatment of disorders of the oesophagus associated with reflux
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
WO2001030381A3 (de) Verwendung von csf-1-inhibitoren
ATE313317T1 (de) Herstellung von therapeutischem mikroschaum
HK1053058A1 (zh) 普拉克索用於治療成癮性疾病的用途
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
PL354533A1 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
SI1268522T1 (sl) Novi antagonisti lhrh, njihova priprava in uporaba kot zdravila
IS6137A (is) Meðhöndlun á hugsýkistruflunum
AU9527001A (en) Treatment of T cell disorders
ZA200108289B (en) Use of osanetant in the production of medicaments used to treat mood disorders.
HUP0200145A3 (en) Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
HK1049122A1 (en) The use of mirtazapine for the treatment of sleep disorders
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
IL155853A0 (en) Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
AU2002226060A1 (en) Compositions containing gangliosides for use in the treatment of skin disorders
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU4838301A (en) Treatment of disorders relating to the serotonergic system
MXPA00012560A (es) Uso de interleucocina-11 para tratar desordenes gastrointestinales.
HUP0402671A3 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments